Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone deacetylase inhibitor based prodrugs
Wenli Fan, Lihui Zhang, Qixao Jiang, et al.
European Journal of Medicinal Chemistry (2020) Vol. 203, pp. 112628-112628
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives
Jingjing Pu, Ting Liu, Xuzhen Wang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Modulation of biological activities in adipose derived stem cells by histone deacetylation
Sallam Hasan Abdallah, Mouna Tabebi, Sawsan Qanadilo, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Targeted intervention of tumor microenvironment with HDAC inhibitors and their combination therapy strategies
Wanli Zhang, Luqi Ge, Yiwen Zhang, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 1
The role of protein acetylation in carcinogenesis and targeted drug discovery
Jingru Yang, Cong Song, Xianquan Zhan
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 28
Epigenetic Regulation of Ferroptosis in Central Nervous System Diseases
Ting Lan, Ting Sun, Chao Wei, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 7, pp. 3584-3599
Closed Access | Times Cited: 18
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
Monica Phimmachanh, Jeremy Z. R. Han, Yolande E. I. O’Donnell, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 41
Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)
Yuxiang Luo, Huilin Li
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8828-8828
Open Access | Times Cited: 40
Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy
Fabian B. Kraft, Maria Hanl, Felix Feller, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 356-356
Open Access | Times Cited: 16
Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)
Guang Lu, Shikai Jin, Su-Wen Lin, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Binding mechanism and distant regulation of histone deacetylase 8 by PCI-34051
Yuxiang Luo, Zhaoyue Yan, Xiakun Chu, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Epigenetic drugs in cancer therapy
Amila Suraweera, Kenneth J. O’Byrne, Derek J. Richard
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
Dual-Action Pt(IV) Prodrugs and Targeted Delivery in Metal-Organic Frameworks: Overcoming Cisplatin Resistance and Improving Anticancer Activity
Larasati Larasati, Witri Wahyu Lestari, Maulidan Firdaus
Bulletin of the Chemical Society of Japan (2022) Vol. 95, Iss. 11, pp. 1561-1577
Closed Access | Times Cited: 18
Advances in the Delivery and Development of Epigenetic Therapeutics for the Treatment of Cancer
Aparajita Ghosh, Ambati Himaja, Swati Biswas, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 12, pp. 5981-6009
Closed Access | Times Cited: 9
Histone deacetylase inhibitors: targeting epigenetic regulation in the treatment of acute leukemia
Tong Xiao, Zhigang Chen, Yutong Xie, et al.
Therapeutic Advances in Hematology (2024) Vol. 15
Open Access | Times Cited: 2
Preclinical and clinical progress for HDAC as a putative target for epigenetic remodeling and functionality of immune cells
Sijia Zhang, Lingjun Zhan, Xue Li, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 13, pp. 3381-3400
Open Access | Times Cited: 15
An updated review of chemical compounds with anti-Toxoplasma gondii activity
Juan B. Rodríguez, Sergio H. Szajnman
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115885-115885
Closed Access | Times Cited: 5
Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cells
Mohamed Abdelsalam, Mariia Zmyslia, Matthias Schmidt, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 2
Open Access | Times Cited: 4
Identification of PI3K/HDAC Dual-targeted inhibitors with subtype selectivity as potential therapeutic agents against solid Tumors: Building HDAC6 potency in a Quinazolinone-based PI3Kδ-selective template
Zhi Li, Can Zhao, Ge He, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 73, pp. 117028-117028
Closed Access | Times Cited: 7
A Novel Hydroxamic Acid-Based Curcumin Derivative as Potent Histone Deacetylase Inhibitor for the Treatment of Glioblastoma
Hao Wang, Lei Shi, Zhimin Wang
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 9
Antibody drug conjugates with hydroxamic acid cargos for histone deacetylase (HDAC) inhibition
Claudio Cianferotti, Valentina Faltoni, Elena Cini, et al.
Chemical Communications (2021) Vol. 57, Iss. 7, pp. 867-870
Open Access | Times Cited: 8
Lysosomal activable Vorinostat carrier-prodrug self-assembling with BPQDs enables photothermal oncotherapy to reverse tumor thermotolerance and metastasis
Yingjie Yu, Bingkai Wang, Miao Sun, et al.
International Journal of Pharmaceutics (2022) Vol. 617, pp. 121580-121580
Closed Access | Times Cited: 4
HDAC1 expression is positively correlated with NADPH oxidase 4-mediated oxidative stress in a mouse model of traumatic brain injury
Yi‐Ming Chen, Yiming Lu, Siyi Xu, et al.
Journal of Neurophysiology (2022) Vol. 127, Iss. 5, pp. 1438-1444
Closed Access | Times Cited: 4
SAR study culminates in a series of HDAC6 selective inhibitors featuring Schisandrin C-analogous Cap as potential immunomodulatory agents for cancer therapy
Qiangqiang Tao, Wei Wei, Xiaoqing Lv, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105992-105992
Closed Access | Times Cited: 4
Evaluation of the Therapeutic Potential of Histone Deacetylase 6 Inhibitors for Primary and Metastatic Uveal Melanoma
Husvinee Sundaramurthi, Zoltán Giricz, Breandán N. Kennedy
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9378-9378
Open Access | Times Cited: 4
Sodium valproate effects on the morphological and neurobehavioral phenotype of zebrafish
Giulia Caioni, Carmine Merola, Monia Perugini, et al.
Environmental Toxicology and Pharmacology (2024) Vol. 110, pp. 104500-104500
Open Access
Page 1 - Next Page

Scroll to top